Neurocrine Uk Limited
14133552
Some Concerns
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 25/05/2026
Due 08/06/2027
Industry
Officers
director · Since 26/05/2022
CHIEF FINANCIAL OFFICER
AMERICAN · UNITED STATES · Age 46
Persons with Significant Control
Neurocrine Biosciences, Inc.
6027, Edgewood Bend Court, San Diego, 92130
Reg: Nasdaq: Nbix · Nasdaq · Corporate
Notified 26/05/2022
CompanyRankvs 57255+ SIC 74909 peers27
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2022
Net Worth
£100
Balance sheet strength
Cash
£100
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
—